Abstract:Background Both hepatolenticular degeneration (HLD) and viral hepatitis B (HBV) can cause hypersplenism, but whether splenectomy is needed or can be performed in HLD patients associated with hypersplenism is still controversial. At present, HLD combined with hypersplenism has not been listed as the indication of splenectomy. Objective This study aimed to investigate the efficacy, risks, and postoperative complications of splenectomy in HLD patients associated with hypersplenism. Methods We retrospectively analyzed the clinical data of 180 HLD patients with hypersplenism who underwent splenectomy in the Department of General Surgery, First Affiliated Hospital of Anhui University of Traditional Chinese Medicine, from January 2001 to December 2015. To evaluate the efficacy of splenectomy, the hemogram of white blood cells (WBC), red blood cells (RBC), platelets (PLT), and the liver function indexes including alanine aminotransferase, aspartate aminotransferase, and total bilirubin were recorded before surgery and 1, 3, 5, 7, and 14 days after surgery. In addition, the clinical data of 142 HBV patients with hypersplenism who underwent splenectomy over the same period were also recorded and compared with that of HLD patients. In particular, aiming to assess the risks of splenectomy in HLD, we also compared postoperative complications and 36-month mortality between the two groups. Result The level of WBC, RBC, and PLT were all elevated after splenectomy in both the HLD group and the HBV group. However, there was no significant difference in the variation of hemogram after splenectomy between the two groups ( P > 0.05). Similarly, the variation of liver function indexes showed no statistical difference between the two groups. In terms of the incidence of postoperative complications including abdominal bleeding, pancreatic leakage, portal vein thrombosis treatment, incision infection, lung infection, and 36-month mortality, there were no significant differences between the two groups. Conclusion After splenectomy, the hemogram as well as liver function in the HLD group improved a lot and showed a consistent tendency with that in the HBV group. Meanwhile, compared to the HBV group, there was no significant difference in the incidence of postoperative complications in the HLD group. All these results indicate that splenectomy in HLD patients combined with hypersplenism is completely feasible and effective.

Therapeutic effects of splenectomy and portal-systemic venous devascularization on hepatolenticular degeneration

Effect of Selective Decongestive Devascularization Shunt of Gastrosplenic Region (SDDS-GSR) on the Serum Levels of IL-4, IL-6 and Sil-2R

[Laparoscopic Splenectomy and Pericardial Devascularization for Treatment of Portal Hypertension Due to Liver Cirrhosis].

Modified Laparoscopic Splenectomy Plus Pericardial Devascularization for the Treatment of Portal Hypertension

Laparoscopic splenectomy and pericardial devascularization with artery pressure perfusion

Separate control of the splenic artery and vein in laparoscopic splenectomy and pericardial devascularization for the treatment of portal hypertension

Comparison of two laparoscopic splenectomy plus pericardial devascularization techniques for management of portal hypertension and hypersplenism

Laparoscopic Splenectomy without Using Endo-GIA Combined with Pericardial Devascularization

Laparoscopic splenectomy plus pericardial devascularization for the treatment of portal hypertension in cirrhotic patients

Clinical observation and risk assessment after splenectomy in hepatolenticular degeneration patients associated with hypersplenism

Effect of splenectomy on cellular immune function of patients with hepatitis C virus related cirrhotic portal hypertensionJ

Laparoscopic Splenectomy Plus Selective Pericardial Devascularization in the Treatment of Portal Hypertension

Initial experience of security implementation of extensive esophagogastric devascularization and splenectomy on 107 patients with portal hypertension and hypersplenism

Impact of splenectomy with periesophagogastric devascularization on liver function of patients with liver cirrhosis and hypersplenism

The Changes of Hepatic Hemodynamics and Functional Hepatic Reserve after Splenectomy with Periesophagogastric Devascularization

Management of gastrointestinal hemorrhage in patients with Wilsons disease

Effects of laparoscopic selective portoazygous devascularization for portal hypertension

Clinical Analysis of 28 Patients on Hepatectomy Combined with Splenctomy for Primary Liver Cancer Associated with Liver Cirrhosis and Hypersplenism

Effects Of Entecavir, Partial Splenic Artery Embolization, And Salvia Miltiorrhiza On Patients With Hypersplenism Due To Hepatitis B Virus-Related Cirrhosis

Era of liver transplantation: combined anatomic splenectomy and anticoagulant therapy in prevention of portal vein thrombosis after splenectomy.

Splenectomy And Selectively Devascularization For Esophageal Bleeding Secondary To Portal Hypertension